Cytek Biosciences reports financials for the quarter ended March 31, 2026, during a conference call on May 7.
Cytek Biosciences released its first-quarter financial results for the period ending March 31, 2026. The company held an earnings call on May 7 to discuss performance and outlook, led by CEO Wenbin Jiang and CFO William McCombe.
The call referenced a slide presentation available on Cytek’s investor relations website. Management noted forward-looking statements regarding business plans and financial projections, subject to risks and uncertainties.
No specific financial figures were disclosed in the initial call transcript summary. Investors were directed to the company’s website for the full earnings release.